CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines.
We license and distribute a portfolio of medicines for CNS, critical care and other conditions, both directly and through strategic partnerships, in over 60 countries worldwide.
A certified B Corp company, our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.
Company Details
- Employees
- 66
- Founded
- -
- Address
- Labs House, 15-19 Bloomsbury Way, London,wc1a 2th,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://cnx-therapeutics.com
- Keywords
- Show more similar pages.
- HQ
- London
Cnx Therapeutics | B Corp™ Certified Questions
Cnx Therapeutics | B Corp™ Certified's website is http://cnx-therapeutics.com
Cnx Therapeutics | B Corp™ Certified's LinkedIn profile is https://uk.linkedin.com/company/cnx-therapeutics
Cnx Therapeutics | B Corp™ Certified has
66 employees.
View email and phone details for 66
employees at Cnx Therapeutics | B Corp™ Certified.
Cnx Therapeutics | B Corp™ Certified's industry is
Pharmaceutical Manufacturing
Cnx Therapeutics | B Corp™ Certified's top competitors are
Cphi,
Inflexion,
Accord Healthcare,
Britannia Pharmaceuticals Ltd,
Pharmanovia,
Torbay Pharma,
Aspire Pharma Ltd,
Qyobo,
Advanz Pharma,
Rosemont Pharmaceuticals.
Cnx Therapeutics | B Corp™ Certified's categories are Pharmaceutical Manufacturing
Cnx Therapeutics | B Corp™ Certified's founding year is 2021
